Connection
Myron Levin to Child
This is a "connection" page, showing publications Myron Levin has written about Child.
|
|
Connection Strength |
|
 |
|
 |
|
0.595 |
|
|
|
-
Janoff EN, Tseng HF, Nguyen JL, Alfred T, Vietri J, McDaniel A, Chilson E, Yan Q, Malhotra D, Isturiz RE, Levin MJ. Incidence and clinical outcomes of pneumonia in persons with down syndrome in the United States. Vaccine. 2023 07 12; 41(31):4571-4578.
Score: 0.058
-
Levin MJ, Huang S, Moscicki AB, Song LY, Read JS, Meyer WA, Saah AJ, Richardson K, Weinberg A. Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine. Vaccine. 2017 03 23; 35(13):1712-1720.
Score: 0.037
-
Brown AEC, Asturias EJ, Melgar M, Antillon-Klussmann FA, Mettler P, Levin MJ. Incidence and consequences of varicella in children treated for cancer in Guatemala. World J Pediatr. 2016 Aug; 12(3):320-326.
Score: 0.036
-
Caruso Brown AE, Cohen MN, Tong S, Braverman RS, Rooney JF, Giller R, Levin MJ. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. Antimicrob Agents Chemother. 2015 Jul; 59(7):3718-25.
Score: 0.033
-
Weinberg A, Huang S, Song LY, Fenton T, Williams P, Patterson J, Tovar-Salazar A, Levin MJ. Immune correlates of herpes zoster in HIV-infected children and youth. J Virol. 2012 Mar; 86(5):2878-81.
Score: 0.026
-
Levin MJ, Moscicki AB, Song LY, Fenton T, Meyer WA, Read JS, Handelsman EL, Nowak B, Sattler CA, Saah A, Radley DR, Esser MT, Weinberg A. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):197-204.
Score: 0.024
-
Weinberg A, Lazar AA, Zerbe GO, Hayward AR, Chan IS, Vessey R, Silber JL, MacGregor RR, Chan K, Gershon AA, Levin MJ. Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis. 2010 Apr 01; 201(7):1024-30.
Score: 0.023
-
Weinberg A, Song LY, Fenton T, Nachman SA, Read JS, Patterson-Bartlett J, Levin MJ. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Res Hum Retroviruses. 2010 Jan; 26(1):51-9.
Score: 0.023
-
Levin MJ, Anderson JP, Seage GR, Williams PL. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr. 2009 Feb 01; 50(2):182-91.
Score: 0.021
-
Levin MJ, DeBiasi RL, Bostik V, Schmid DS. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis. 2008 Nov 15; 198(10):1444-7.
Score: 0.021
-
Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, Kemble G, Allende M, Hultquist M, Yi T, Nowak B, Weinberg A. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine. 2008 Aug 05; 26(33):4210-7.
Score: 0.020
-
Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S200-6.
Score: 0.020
-
Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells. J Infect Dis. 2006 Jul 15; 194(2):247-55.
Score: 0.018
-
Weinberg A, Wiznia AA, Lafleur BJ, Shah S, Levin MJ. Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART. AIDS Res Hum Retroviruses. 2006 Mar; 22(3):283-8.
Score: 0.017
-
Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2004 Jul 15; 190(2):267-70.
Score: 0.015
-
Weinberg A, Huang S, Moscicki AB, Saah A, Levin MJ. Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children. AIDS. 2018 04 24; 32(7):851-860.
Score: 0.010
-
Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med. 2018 03; 15(3):e1002514.
Score: 0.010
-
Conway JH, Weinberg A, Ashley RL, Amer J, Levin MJ. Viral meningitis in a preadolescent child caused by reactivation of latent herpes simplex (type 1). Pediatr Infect Dis J. 1997 Jun; 16(6):627-9.
Score: 0.010
-
Buda K, Tubergen DG, Levin MJ. The frequency and consequences of varicella exposure and varicella infection in children receiving maintenance therapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1996 May; 18(2):106-12.
Score: 0.009
-
Levin MJ, Rotbart HA, Hayward AR. Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella. J Infect Dis. 1995 May; 171(5):1383-4.
Score: 0.008
-
Levin MJ. Treatment and prevention options for respiratory syncytial virus infections. J Pediatr. 1994 May; 124(5 Pt 2):S22-7.
Score: 0.008
-
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):309-18.
Score: 0.008
-
Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb; 58(3):e44-100.
Score: 0.007
-
Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI. Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy. Vaccine. 2013 Oct 01; 31(42):4782-90.
Score: 0.007
-
Toback SL, Levin MJ, Block SL, Belshe RB, Ambrose CS, Falloon J. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine. Expert Rev Vaccines. 2012 Nov; 11(11):1293-303.
Score: 0.007
-
Weinberg A, Song LY, Saah A, Brown M, Moscicki AB, Meyer WA, Bryan J, Levin MJ. Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children. J Infect Dis. 2012 Oct; 206(8):1309-18.
Score: 0.007
-
Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, Pelton SI, Rosenblatt HM. Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2012 Aug 15; 206(4):512-22.
Score: 0.007
-
Levin MJ, Weinstein MP, Sumaya CV, Gooch M, Osband M, Rhodes G, Ackley AM, Wren CG, Podgore JK. The rapid diagnosis of infectious mononucleosis using an ELISA that detects IgM antibody to a peptide component of Epstein-Barr virus nuclear antigen. Diagn Microbiol Infect Dis. 1991 Jul-Aug; 14(4):287-91.
Score: 0.006
-
Schwarz TF, Kocken M, Pet?j? T, Einstein MH, Spaczynski M, Louwers JA, Pedersen C, Levin M, Zahaf T, Poncelet S, Hardt K, Descamps D, Dubin G. Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine. Hum Vaccin. 2010 Dec; 6(12):1054-61.
Score: 0.006
-
Ambrose CS, Levin MJ, Belshe RB. The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses. 2011 Mar; 5(2):67-75.
Score: 0.006
-
Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr. 2010 Oct; 55(2):189-96.
Score: 0.006
-
Abzug MJ, Warshaw M, Rosenblatt HM, Levin MJ, Nachman SA, Pelton SI, Borkowsky W, Fenton T. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis. 2009 Sep 15; 200(6):935-46.
Score: 0.006
-
Rosenberg NL, Rotbart HA, Abzug MJ, Ringel SP, Levin MJ. Evidence for a novel picornavirus in human dermatomyositis. Ann Neurol. 1989 Aug; 26(2):204-9.
Score: 0.006
-
Gershon AA, Levin MJ, Weinberg A, Song LY, LaRussa PS, Steinberg SP, Bartlett P. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella. Pediatr Infect Dis J. 2009 Jul; 28(7):653-5.
Score: 0.005
-
Gershon AA, Arvin AM, Levin MJ, Seward JF, Schmid DS. Varicella vaccine in the United States: a decade of prevention and the way forward. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S39-40.
Score: 0.005
-
Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics. 2007 Nov; 120(5):e1190-202.
Score: 0.005
-
Loparev VN, Rubtcova E, Seward JF, Levin MJ, Schmid DS. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis. 2007 Feb 15; 195(4):502-10.
Score: 0.005
-
Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2006 Oct; 25(10):920-9.
Score: 0.005
-
Muller WJ, Levin MJ, Shin YK, Robinson C, Quinones R, Malcolm J, Hild E, Gao D, Giller R. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis. 2005 Dec 15; 41(12):1812-6.
Score: 0.004
-
Lauer BA, Masters HA, Wren CG, Levin MJ. Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol. 1985 Nov; 22(5):782-5.
Score: 0.004
-
Schuval S, Lindsey JC, Stapleton JT, Van Dyke RB, Palumbo P, Mofenson LM, Oleske JM, Cervia J, Kovacs A, Dankner WN, Smith E, Nowak B, Ciupak G, Webb N, Eagle M, Smith D, Hennessey R, Goodman-Kerkau M, Klinzman D, Hess G, Zdunek D, Levin MJ. GB virus C infection in children with perinatal human immunodeficiency virus infection. Pediatr Infect Dis J. 2005 May; 24(5):417-22.
Score: 0.004
-
Bowden RA, McGavren L, Hayward AR, Levin MJ. Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system. J Clin Microbiol. 1984 Oct; 20(4):696-700.
Score: 0.004
-
Schuval S, Van Dyke RB, Lindsey JC, Palumbo P, Mofenson LM, Oleske JM, Cervia J, Kovacs A, Dankner WN, Smith E, Nowak B, Ciupak G, Webb N, Eagle M, Smith D, Hennessey R, Goodman-Kerkau M, Levin MJ. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med. 2004 Oct; 158(10):1007-13.
Score: 0.004
-
Starr SE, McFarland EJ, Muresan P, Fenton T, Pitt J, Douglas SD, Deveikis A, Levin MJ, Rathore MH. Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children. AIDS. 2003 Oct 17; 17(15):2181-9.
Score: 0.004
-
Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med. 1982 Feb 11; 306(6):343-6.
Score: 0.003
-
Chan KH, Winslow CP, Levin MJ, Abzug MJ, Shira JE, Liu AH, Simoes EA, Strain JD, Stool SE. Clinical practice guidelines for the management of chronic sinusitis in children. Otolaryngol Head Neck Surg. 1999 Mar; 120(3):328-34.
Score: 0.003
-
Zaia JA, Levin MJ. Varicella vaccine. Pediatrics. 1979 Feb; 63(2):348.
Score: 0.003
-
Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol. 1994 Oct; 98(1):128-33.
Score: 0.002
-
Rotbart HA, Levin MJ, Hayward AR. Immune responses to varicella zoster virus infections in healthy children. J Infect Dis. 1993 Jan; 167(1):195-9.
Score: 0.002
-
Ogle JW, Toltzis P, Parker WD, Alvarez N, McIntosh K, Levin MJ, Lauer BA. Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis. 1989 Apr; 159(4):748-50.
Score: 0.001
-
Sullender WM, Arvin AM, Diaz PS, Connor JD, Straube R, Dankner W, Levin MJ, Weller S, Blum MR, Chapman S. Pharmacokinetics of acyclovir suspension in infants and children. Antimicrob Agents Chemother. 1987 Nov; 31(11):1722-6.
Score: 0.001
-
Giller RH, Bowden RA, Levin MJ, Walker LJ, Tubergen DG, Hayward AR. Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms. J Clin Immunol. 1986 Nov; 6(6):472-80.
Score: 0.001
-
Chilmonczyk BA, Levin MJ, McDuffy R, Hayward AR. Characterization of the human newborn response to herpesvirus antigen. J Immunol. 1985 Jun; 134(6):4184-8.
Score: 0.001
-
Meyers JD, Leszczynski J, Zaia JA, Flournoy N, Newton B, Snydman DR, Wright GG, Levin MJ, Thomas ED. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med. 1983 Apr; 98(4):442-6.
Score: 0.001
-
Zaia JA, Levin MJ, Preblud SR, Leszczynski J, Wright GG, Ellis RJ, Curtis AC, Valerio MA, LeGore J. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis. 1983 Apr; 147(4):737-43.
Score: 0.001
-
Meyers JD, Wade JC, Mitchell CD, Saral R, Lietman PS, Durack DT, Levin MJ, Segreti AC, Balfour HH. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med. 1982 Jul 20; 73(1A):229-35.
Score: 0.001
-
Leclair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N Engl J Med. 1980 Feb 21; 302(8):450-3.
Score: 0.001
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|